Study in Leucocytes From Patients With Type 1 and Type 2 Diabetes Genetic Markers of Inflammation and Oxidative Stress (TÉLOMÈRES/ CANDIDATE GENES) According to the Type A or Type B Behavior Profile

Not Applicable

Terminated

• Conditions: Patients With Type 1 or Type 2 Diabetes; Patients With a Type A or B Behaviour Profile
• Interventions: Other: Blood sample of 12 ml

• Registration Number: NCT02080741
• Lead Sponsor: Centre Hospitalier Universitaire Dijon

Brief Summary

This study will include 100 patients with Type 1 and Type 2 diabetes, split into 2 groups of 50 patients according to their behaviour type, and their adaptation to different factors of stress encountered in their lives:

* the first group will consist of patients with a characteristic Type A behaviour profile, that is to say patients with a "proactive, impatient" behaviour pattern

* the second group will consist of patients with a characteristic Type B behaviour profile that is to say patients with a "calm, slow" behaviour pattern The objective is to know if the different behaviour patterns are associated with distinct biological markers likely to influence the evolution of the diabetes.

Participation in this study will be approximately 1h30, patients will participate ONCE ONLY:

1. they will answer simple questions about their disease and then complete 3 questionnaires each with 14 items.

2. they will meet a clinical psychologist for an interview lasting approximately 45 minutes recorded on an audio recorder. The consultation will be used to seek links between the psyche and the disease.

3. they will provide one blood sample of 12 ml (equivalent to a soup spoon) drawn in the morning.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2014-03-05
• Study First Submitted QC: 2014-03-05
• Study First Posted: 2014-03-06
• Study Start: 2014-09-23
• Primary Completion: 2018-05-29
• Status Verified: 2024-02
• Last Update Submitted: 2024-02-20
• Last Update Posted: 2024-02-21

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 57

Inclusion Criteria

• Patients who have provided written informed consent
• Patients with type 1 or type 2 diabetes
• Patient admitted for a consultation, as out or in-patients to the Endocrinology-Diabetology-Metabolic diseases department of Dijon CHU
• Patient > 18 years
• Patient with either a characteristic Type A behaviour profile (Bortner > 210), or a characteristic Type B behaviour profile (Bortner<154)

Exclusion Criteria

• Persons not covered by national health insurance
• Adults under guardianship or wards of court or not intellectually independent
• Patients without diabetes
• Patients with a mixed A/B behaviour profile (154< Bortner score <210)
• Pregnant or breast-feeding women

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Type B behaviour profile	Blood sample of 12 ml	-
Type A behaviour profile	Blood sample of 12 ml	-

Primary Outcome Measures

Name	Time	Method
Telomere length	Baselines

Secondary Outcome Measures

Name	Time	Method
Level of expression of candidate genes	Baselines

Trial Locations

Locations (1)

CHU de DIJON; 🇫🇷 Dijon, France